BCL2 and prostate carcinoma: It is suggested that androgen-mediated mechanisms may act through Bcl-2-mediated apoptotic pathways (99).The overexpression of Bcl-2 in prostate cancer safeguards the tumor cells from apoptosis (100, 101).